Vivosim Labs Notes FDA's Direct Final Rule Clarifying That Non-Animal Methods Can Be Used Where Appropriate For Testing Safety Of Drugs And Biological Products For Human Use

The FDA has issued a Direct Final Rule allowing the use of non-animal methods for testing the safety of drugs and biological products, replacing the term 'animal tests' with 'nonclinical tests.' VivoSim Labs offers liver tissue models that can identify drug candidates likely to cause liver toxicity and other side effects, addressing major causes of drug failures. Their human cell-based models help clients de-risk compounds and rank clinical safety risks earlier in the development process.